Get up to speed on herpes simplex virus (HSV-1/HSV-2) epidemiology, novel antibodies, vaccine development, and cure ...

SAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. ("Excision", the "Company"), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...

Announcing a new publication for Acta Materia Medica journal. Owing to environmental and lifestyle changes in modern society, physical and mental stress is on the rise among the population in ...

Herpes simplex virus is a common infection that typically appears in and around the mouth (oral herpes) or the genitals (genital herpes). Ulcers may cause pain but usually resolve within a few days or ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Some studies found herpes simplex virus 1 increased ...

“To completely cure HSV-1, the idea is to prevent the virus from going into latency, because then, it’s protected by our own bodies,” said Esther González-Almela, a virologist at the Guangdong Academy ...

- Treatment with EBT-104 led to complete elimination of viral shedding in 92% eyes of treated rabbits - Excision’s proprietary gene editing technology holds unique, curative potential to address the ...

- Excision’s proprietary gene editing technology holds unique, curative potential to address the leading cause of corneal blindness in the United States - Global incidence of HSV keratitis is ...